US2017037090A1PendingUtilityA1

Recombinant expression of multiprotein complexes using polygenes

Assignee: ETH ZUERICHPriority: Nov 8, 2005Filed: Oct 26, 2016Published: Feb 9, 2017
Est. expiryNov 8, 2025(expired)· nominal 20-yr term from priority
C12N 15/86C12N 2799/026C07K 2319/21C07K 2319/50C12N 2710/14043C07K 2319/80C07K 14/4702C12N 15/85A61P 43/00C12N 15/866C12N 15/79C12N 15/10A61K 48/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a recombinant polynucleotide encoding a polygene coding for at least three polypeptides wherein at least one of the genes constituting the polygene is of non-viral origin, at least two of the polypeptides encoded by the genes constituting the polygene are each capable of at least transiently interacting with at least one other polypeptide encoded by a gene of said polygene, and the genes constituting the polygene are each connected to one another by a sequence coding for at least one protease cleavage site. The present invention also relates to polyproteins encoded by the polygene. Further embodiments of the present invention are a vector containing the recombinant polypeptide, a host cell containing the recombinant polypeptide and/or the vector and a non-human transgenic animal transformed with the recombinant polypeptide and/or the vector. The present invention also relates to methods for the production of the polynucleotide and for the manufacture of multiprotein complexes. The embodiments of the present invention are particularly useful in gene therapy, drug candidate screening, vaccine production and crystallisation of multiprotein complexes for structural investigations.

Claims

exact text as granted — not AI-modified
1 - 36 . (canceled) 
     
     
         37 . A polynucleotide encoding at least two polygenes, wherein
 each polygene has a single open reading frame (ORF),   each polygene comprises at least three genes each coding for a biologically active polypeptide,   at least two of the biologically active polypeptides encoded by any genes of the at least two polygenes are of non-viral origin,   at least two of the biologically active polypeptides encoded by any genes of the at least two polygenes are each capable of at least transiently interacting with at least one of the other biologically active polypeptides, and   the genes constituting each polygene are connected to one another by a sequence coding for at least one self-cleaving peptide, and   at least one polygene comprises more than one copy of a gene coding for a biologically active polypeptide.   
     
     
         38 . A transgenic non-human animal transformed with the polynucleotide of  claim 37 . 
     
     
         39 . A host cell comprising the polynucleotide of  claim 37 .

Join the waitlist — get patent alerts

Track US2017037090A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.